We are live on ! Find out more
MS

Maven Securities Portfolio holdings

AUM $5.2B
1-Year Est. Return 44.01%
This Fund
S&P 500
This Quarter Est. Return
+21.1%
1 Year Est. Return
+44.01%
3 Year Est. Return
+102.83%
5 Year Est. Return
+136.18%
10 Year Est. Return
AUM
$1.21B
AUM Growth
-$248M
Cap. Flow
-$400M
Cap. Flow %
-32.99%
Top 10 Hldgs %
23.94%
Holding
810
New
297
Increased
109
Reduced
151
Closed
223

Sector Composition

Rank Sector Weight
1 Healthcare 13.03%
2 Technology 7.51%
3 Consumer Discretionary 5.23%
4 Financials 5.2%
5 Industrials 4.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRSVU
226
DELISTED
Gores Holdings V, Inc. Unit
GRSVU
$1.04M 0.09%
+100,000
New +$1.02M
GLIBA
227
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
$1.04M 0.09%
+12,612
New +$994K
VTRS icon
228
Viatris
VTRS
$20.1B
$1.04M 0.09%
70,000
CAT icon
229
PUT
Caterpillar
CAT
$409B
$1.04M 0.09%
6,900
-11,700
-63% -$1.64M
BFT.U
230
DELISTED
Foley Trasimene Acquisition Corp. II Units, each consisting of one share of Class A common stock, an
BFT.U
$1.03M 0.08%
+100,000
New +$1.02M
ABT icon
231
PUT
Abbott
ABT
$180B
$1.03M 0.08%
9,500
+3,400
+56% +$345K
BKNG icon
232
PUT
Booking.com
BKNG
$138B
$1.03M 0.08%
15,000
-10,000
-40% -$702K
TLMD
233
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
$1.02M 0.08%
+100,000
New +$1.03M
VITL icon
234
Vital Farms
VITL
$558M
$1.02M 0.08%
+25,000
New +$944K
FISV
235
PUT
Fiserv Inc
FISV
$27.2B
$1.02M 0.08%
9,800
+4,800
+96% +$478K
HZNP
236
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.01M 0.08%
+13,038
New +$897K
HPX.U
237
DELISTED
HPX Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
HPX.U
$1.01M 0.08%
+100,000
New +$1.01M
MTCH icon
238
Match Group
MTCH
$8.84B
$1.01M 0.08%
9,237
-17,296
-65% -$1.83M
BAC icon
239
CALL
Bank of America
BAC
$435B
$1.01M 0.08%
41,800
+15,600
+60% +$388K
LMND icon
240
Lemonade
LMND
$4.62B
$1M 0.08%
+20,000
New +$1.26M
PAGS icon
241
PagSeguro Digital
PAGS
$2.57B
$999K 0.08%
26,287
+12,781
+95% +$497K
STNE icon
242
StoneCo
STNE
$2.62B
$993K 0.08%
+18,623
New +$890K
XNTK icon
243
CALL
State Street SPDR NYSE Technology ETF
XNTK
$2.06B
$992K 0.08%
10,700
-117,100
-92% -$13.1M
AHACU
244
DELISTED
Alpha Healthcare Acquisition Corp Unit
AHACU
$991K 0.08%
+100,000
New +$995K
NVDA icon
245
NVIDIA
NVDA
$5.01T
$989K 0.08%
73,040
-14,280
-16% -$166K
ALGN icon
246
PUT
Align Technology
ALGN
$12B
$985K 0.08%
3,000
+500
+20% +$153K
BFLY icon
247
Butterfly Network
BFLY
$1.72B
$984K 0.08%
+99,999
New +$991K
SPLK
248
PUT
DELISTED
Splunk Inc
SPLK
$983K 0.08%
5,200
-600
-10% -$120K
ETSY icon
249
Etsy
ETSY
$7.65B
$976K 0.08%
+7,866
New +$921K
GILD icon
250
Gilead Sciences
GILD
$161B
$974K 0.08%
15,513
+9,132
+143% +$633K

Similar funds

Maven Securities's Q3 2020 Portfolio in Review

As of Q3 2020, Maven Securities held 810 positions worth $1.21B, down 17% from $1.46B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Maven Securities withdrew a net $400M in Q3 2020, closing 223 positions and reducing 151 holdings. Its most notable exit was Agios Pharmaceuticals, an estimated $16M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 5.9% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Maven Securities opened a new position in Adaptive Biotechnologies worth $18M.

  • Maven Securities's largest Q3 2020 buy was Adaptive Biotechnologies: 375,000 shares worth $18M.
  • Maven Securities added most to Caesars Entertainment in Q3 2020, an estimated $16.2M increase.
  • Maven Securities's biggest Q3 2020 reduction was BHP, cutting an estimated $10.7M.
  • Maven Securities fully exited Agios Pharmaceuticals in Q3 2020, selling an estimated $16M.
  • Maven Securities's ten largest holdings make up 24% of its $1.21B portfolio in Q3 2020.
  • Maven Securities opened 297 new positions and closed 223 in Q3 2020.
  • Maven Securities's portfolio value fell 17% quarter-over-quarter to $1.21B.

Based on Maven Securities's 13F filing for Q3 2020, filed 13 Nov 2020.